Bicycle Therapeutics plc (BCYC) Financials

$9.79

south_east
-$0.44 (-4.3%)
Day's range
$9.58
Day's range
$10.15

BCYC Income statement / Annual

Last year (2024), Bicycle Therapeutics plc's total revenue was $35.28 M, an increase of 30.76% from the previous year. In 2024, Bicycle Therapeutics plc's net income was -$169.03 M. See Bicycle Therapeutics plc,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $35.28 M $26.98 M $14.46 M $11.70 M $10.39 M $13.80 M $7.14 M $2.06 M $0.00
Cost of Revenue $0.00 $6.47 M $3.69 M $44.88 M $33.15 M $25.54 M $20.76 M $11.87 M $269,289.00
Gross Profit $35.28 M $20.51 M $10.78 M -$33.18 M -$22.76 M -$11.74 M -$13.63 M -$9.81 M -$269,289.00
Gross Profit Ratio 1 0.76 0.75 -2.84 -2.19 -0.85 -1.91 -4.76 0
Research and Development Expenses $172.97 M $156.50 M $81.61 M $44.88 M $33.15 M $25.54 M $20.76 M $11.87 M $9.77 M
General & Administrative Expenses $72.18 M $59.83 M $49.51 M $32.44 M $29.20 M $14.56 M $8.12 M $6.41 M $3.78 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$325,109.00
Selling, General & Administrative Expenses $72.18 M $59.83 M $49.51 M $32.44 M $29.20 M $14.56 M $8.12 M $6.41 M $3.45 M
Other Expenses $0.00 $594,000.00 $0.00 $0.00 $0.00 -$5.38 M -$665,000.00 -$119,000.00 $0.00
Operating Expenses $245.15 M $216.92 M $131.12 M $77.32 M $62.35 M $40.10 M $28.88 M $18.27 M $13.22 M
Cost And Expenses $245.15 M $216.92 M $131.12 M $77.32 M $62.35 M $40.10 M $28.88 M $18.27 M $13.49 M
Interest Income $34.28 M $14.00 M $5.76 M $120,000.00 $683,000.00 $814,000.00 $169,000.00 $50,000.00 $8,000.00
Interest Expense $1.73 M $3.26 M $3.34 M $2.98 M $457,000.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $7.17 M $6.55 M $3.69 M $1.41 M $1.29 M $963,973.00 $710,796.00 $335,559.00 $269,289.00
EBITDA -$164.89 M -$183.40 M -$112.96 M -$64.08 M -$50.39 M -$30.03 M -$21.49 M -$15.88 M -$13.26 M
EBITDA Ratio -4.67 -6.8 -7.67 -5.6 -4.94 -1.91 -2.95 -7.71 0
Operating Income Ratio -5.95 -7.04 -8.07 -5.61 -5 -1.91 -3.05 -7.87 0
Total Other Income/Expenses Net $36.08 M $10.74 M $2.41 M -$2.86 M $226,000.00 -$4.56 M -$496,000.00 -$69,000.00 -$37,895.00
Income Before Tax -$173.80 M -$179.21 M -$114.24 M -$68.48 M -$51.73 M -$30.86 M -$22.24 M -$16.28 M -$13.53 M
Income Before Tax Ratio -4.93 -6.64 -7.9 -5.85 -4.98 -2.24 -3.12 -7.9 0
Income Tax Expense -$4.77 M $1.46 M -$1.52 M -$1.66 M -$724,000.00 -$254,000.00 -$396,000.00 -$23,000.00 -$20,944.00
Net Income -$169.03 M -$180.66 M -$112.72 M -$66.82 M -$51.01 M -$30.61 M -$21.85 M -$16.26 M -$13.51 M
Net Income Ratio -4.79 -6.7 -7.79 -5.71 -4.91 -2.22 -3.06 -7.89 0
EPS -0.29 -5.08 -3.8 -2.67 -2.66 -2.77 -1.64 -1.22 -0.76
EPS Diluted -0.29 -5.08 -3.8 -2.67 -2.66 -2.77 -1.64 -1.22 -0.76
Weighted Average Shares Out $582.08 M $35.59 M $29.66 M $25.06 M $19.15 M $11.05 M $13.29 M $13.29 M $17.70 M
Weighted Average Shares Out Diluted $582.08 M $35.59 M $29.66 M $25.06 M $19.15 M $11.05 M $13.29 M $13.29 M $17.70 M
Link